» Articles » PMID: 31861212

From Samples to Insights into Metabolism: Uncovering Biologically Relevant Information in LC-HRMS Metabolomics Data

Overview
Journal Metabolites
Publisher MDPI
Date 2019 Dec 22
PMID 31861212
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Untargeted metabolomics (including lipidomics) is a holistic approach to biomarker discovery and mechanistic insights into disease onset and progression, and response to intervention. Each step of the analytical and statistical pipeline is crucial for the generation of high-quality, robust data. Metabolite identification remains the bottleneck in these studies; therefore, confidence in the data produced is paramount in order to maximize the biological output. Here, we outline the key steps of the metabolomics workflow and provide details on important parameters and considerations. Studies should be designed carefully to ensure appropriate statistical power and adequate controls. Subsequent sample handling and preparation should avoid the introduction of bias, which can significantly affect downstream data interpretation. It is not possible to cover the entire metabolome with a single platform; therefore, the analytical platform should reflect the biological sample under investigation and the question(s) under consideration. The large, complex datasets produced need to be pre-processed in order to extract meaningful information. Finally, the most time-consuming steps are metabolite identification, as well as metabolic pathway and network analysis. Here we discuss some widely used tools and the pitfalls of each step of the workflow, with the ultimate aim of guiding the reader towards the most efficient pipeline for their metabolomics studies.

Citing Articles

Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples.

Avram L, Crisan D, Moldovan R, Bogos L, Iuga C, Andras D Cancers (Basel). 2025; 17(3).

PMID: 39941796 PMC: 11816151. DOI: 10.3390/cancers17030427.


Multiplatform Metabolomics: Enhancing the Severity Risk Prognosis of SARS-CoV-2 Infection.

Lima V, Morais S, Ferreira V, Almeida M, Silva M, de A Lopes T ACS Omega. 2024; 9(46):45746-45758.

PMID: 39583673 PMC: 11579725. DOI: 10.1021/acsomega.4c02557.


Metabolic fate of the natural anticancer agent cucurbitacin B: an LC-MS/MS-enabled profiling of its major phase I and II conjugates in vivo.

Liu W, Xu D, Meng H, Wang C, Feng X, Wang J Anal Bioanal Chem. 2024; 416(29):7043-7062.

PMID: 39441433 DOI: 10.1007/s00216-024-05608-y.


Statistical analysis of feature-based molecular networking results from non-targeted metabolomics data.

Pakkir Shah A, Walter A, Ottosson F, Russo F, Navarro-Diaz M, Boldt J Nat Protoc. 2024; 20(1):92-162.

PMID: 39304763 DOI: 10.1038/s41596-024-01046-3.


Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Rakusanova S, Cajka T Physiol Res. 2024; 73(S1):S165-S183.

PMID: 39212142 PMC: 11412346. DOI: 10.33549/physiolres.935443.


References
1.
Fabregat A, Korninger F, Viteri G, Sidiropoulos K, Marin-Garcia P, Ping P . Reactome graph database: Efficient access to complex pathway data. PLoS Comput Biol. 2018; 14(1):e1005968. PMC: 5805351. DOI: 10.1371/journal.pcbi.1005968. View

2.
Li H, Cai Y, Guo Y, Chen F, Zhu Z . MetDIA: Targeted Metabolite Extraction of Multiplexed MS/MS Spectra Generated by Data-Independent Acquisition. Anal Chem. 2016; 88(17):8757-64. DOI: 10.1021/acs.analchem.6b02122. View

3.
Mills E, Pierce K, Jedrychowski M, Garrity R, Winther S, Vidoni S . Accumulation of succinate controls activation of adipose tissue thermogenesis. Nature. 2018; 560(7716):102-106. PMC: 7045287. DOI: 10.1038/s41586-018-0353-2. View

4.
Broadhurst D, Goodacre R, Reinke S, Kuligowski J, Wilson I, Lewis M . Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018; 14(6):72. PMC: 5960010. DOI: 10.1007/s11306-018-1367-3. View

5.
Guijas C, Montenegro-Burke J, Domingo-Almenara X, Palermo A, Warth B, Hermann G . METLIN: A Technology Platform for Identifying Knowns and Unknowns. Anal Chem. 2018; 90(5):3156-3164. PMC: 5933435. DOI: 10.1021/acs.analchem.7b04424. View